Genistein sodium dihydrate (Axcentua Pharmaceuticals)

N/A

Report date: 2026/03/12 20:00:16

Base Information

Drug NameGenistein sodium dihydrate (Axcentua Pharmaceuticals)
Drug Alias NameAXP-107-11
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsTopoisomerase II inhibitorsProtein-tyrosine kinases inhibitors
TargetsTopoisomerase IIProtein-tyrosine kinases
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAxcentua Pharmaceuticals Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxcentua Pharmaceuticals Ab
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A